BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

Qube Research & Technologies Ltd's Holding History (CIK: 0001729829)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 2,164,162 Value ($000) $16,880 Avg Close $7.23 Range $6.00 - $8.17
Q3 2025
Shares 2,410,362 Value ($000) $18,295 Avg Close $8.33 Range $7.42 - $9.23
Q2 2025
Shares 2,373,489 Value ($000) $21,266 Avg Close $9.31 Range $6.02 - $11.31
Q1 2025
Shares 940,665 Value ($000) $7,055 Avg Close $8.07 Range $6.96 - $9.50
Q4 2024
Shares 272,844 Value ($000) $2,052 Avg Close $7.59 Range $6.85 - $8.44
Q3 2024
Shares 253,901 Value ($000) $1,930 Avg Close $7.60 Range $6.17 - $8.88
Q1 2024
Shares 667,394 Value ($000) $3,390 Avg Close $5.62 Range $4.82 - $7.75
Q4 2023
Shares 1,028,503 Value ($000) $6,161 Avg Close $5.79 Range $4.83 - $7.06
Q2 2023
Shares 214,095 Value ($000) $1,507 Avg Close $8.02 Range $6.87 - $9.07
Q2 2021
Shares 40,503 Value ($000) $640 Avg Close $13.59 Range $9.23 - $17.74
Q1 2021
Shares 46,252 Value ($000) $470 Avg Close $10.31 Range $7.27 - $14.24
Q2 2020
Shares 220,891 Value ($000) $1,053 Avg Close $3.99 Range $1.80 - $6.29
Q4 2019
Shares 14,836 Value ($000) $51 Avg Close $2.52 Range $1.38 - $3.48